Didanosine (Aurobindo Pharma Limited)


Welcome to the PulseAid listing for the Didanosine drug offered from Aurobindo Pharma Limited. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aurobindo Pharma Limited
NON-PROPRIETARY NAME: Didanosine
SUBSTANCE NAME: DIDANOSINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-09-24
END MARKETING DATE: 0000-00-00


Didanosine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDidanosine from Aurobindo Pharma Limited
LABELER NAME: Aurobindo Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/1)
START MARKETING DATE: 2008-09-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65862-310_d065d7cf-bc3e-4c46-b63c-2544c8d25b6d
PRODUCT NDC: 65862-310
APPLICATION NUMBER: ANDA090094

Other DIDANOSINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedDidanosine
Bristol-Myers Squibb CompanyVIDEX
Physicians Total Care, Inc.Didanosine
State of Florida DOH Central PharmacyDidanosine
Teva Pharmaceuticals USA, Inc.Didanosine